|
It's a shame
Thanks Lanie for another great article!
It is a shame that many onc's are not up with current
data..or if they are just refuse to consider any change.
This at the exspense of their patient (have to wonder if
it were their wife, daughter, mother) if that would change
the mind a bit? Also a great shame that many dr. still do not
even know about the TOPO testing? As Dr Slamon noted
only 8% have this over active gene. Shame that many
woman are subjected to additional unnecessary risks!
Fighting this disease takes on many battle fields
THANK GOD FOR THIS SITE.
and once again GOD BLESS JOE AND CHRISTINE.
Regards,
Jean
__________________
Stage 1, Grade 1, 3/30/05
Lumpectomy 4/15/05 - 6MM IDC
Node Neg. (Sentinel node)
ER+ 90% / PR-, Her2+++ by FISH
Ki-67 40%
Arimidex 5/05
Radiation 32 trt, 5/30/05
Oncotype DX test 4/17/06, 31% high risk
TOPO 11 neg. 4/06
Stopped Arimidex 5/06
TCH 5/06, 6 treatments
Herceptin 5/06 - for 1 yr.
9/06 Completed chemo
Started Femara Sept. 2006
|